. Author manuscript; available in PMC: 2010 Apr 1.

Published in final edited form as: J Nutr Sci Vitaminol (Tokyo). 2009 Apr;55(2):112–119. doi: 10.3177/jnsv.55.112

Table 3.

Baseline measures of plasma PIVKA-II by VKORC1 and GGCX genotype.

Gene SNP	Allele	n (%)	PIVKA-II¹, ng/mL	p
VKORC1 rs17878544	AA	398 (96)	2.19 (1.85–2.55)
	AG	18 (4)	1.89 (1.36–2.43)	0.233
VKORC1 rs8050894	CC	152 (37)	2.07 (1.70–2.45)
	CG	180 (44)	2.26 (1.90–2.62)
	GG	77 (19)	2.07 (1.70–2.43)	0.105
VKORC1 rs7294	GG	156 (38)	2.21 (1.84–2.50)
	AG	197 (47)	2.15 (1.79–2.50)
	AA	58 (14)	1.99 (1.59–2.39)	0.311
GGCX rs10187424	TT	150 (36)	2.13 (1.76–2.49)
	CT	198 (48)	2.17 (1.81–2.53)
	CC	68 (16)	2.10 (1.71–2.49)	0.793
GGCX rs7568458	AA	137 (33)	2.10 (1.75–2.47)
	AT	201 (48)	2.18 (1.83–2.54)
	TT	78 (19)	2.11 (1.71–2.49)	0.666
GGCX rs699664	GG	212 (51)	2.07 (1.72–2.43)
	GA	169 (40)	2.17 (1.80–2.54)
	AA	35 (8)	2.28 (1.86–2.71)	0.329
GGCX rs2028898	CC	235 (56)	2.10 (1.75–2.45)
	CT	160 (38)	2.17 (1.80–2.54)
	TT	21 (5)	2.26 (1.78–2.74)	0.583

Adjusted for age, gender, BMI, smoking, plasma triglycerides, dietary phylloquinone, ethnicity, and presented as mean (95% CI).